Human Genome Sciences and Orexigen showed their Lupus and diet drug data.
Onyx Pharmaceuticals was a surprise guest with its mid-stage breast cancer results on Wednesday.
Celgene announced it had stopped a multiple myeloma study early because the drug appears to be working so well.
Will next week be just as exciting in the biopharma industry/
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment